EDGEWELL PERSONAL CARE Co (EPC) stock
EPCNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Financials through Q4 FY2026, quarter ended Sep 30, 2026Last filing: 10-K on Nov 13, 2026Score 4/3045% above fair value
$27.28−1.46 (-5.08%)
Close on Nov 13, 2026Market cap $1.26BP/E –Yield –
Edgewell Personal Care r&d expenses
Research and development expenses are spending on new products and technology.
Edgewell Personal Care's R&D Expenses for the twelve months ending Sep 30, 2026 was $57.50M, up 3.4% year over year. For fiscal 2026 it was $57.50M, up 3.4% from the year before. Over ten years it grew -2.2% a year on average. The highest annual figure on record is $112.50M in fiscal 2012.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Sep 30, 2026 | $57.50M | +3.4% |
| FY2025 | Sep 30, 2025 | $55.60M | -1.4% |
| FY2024 | Sep 30, 2024 | $56.40M | -3.6% |
| FY2023 | Sep 30, 2023 | $58.50M | +5.4% |
| FY2022 | Sep 30, 2022 | $55.50M | -4.0% |
| FY2021 | Sep 30, 2021 | $57.80M | +4.5% |
| FY2020 | Sep 30, 2020 | $55.30M | +3.4% |
| FY2019 | Sep 30, 2019 | $53.50M | -12.4% |
| FY2018 | Sep 30, 2018 | $61.10M | -9.6% |
| FY2017 | Sep 30, 2017 | $67.60M | -6.0% |
| FY2016 | Sep 30, 2016 | $71.90M | +1.3% |
| FY2015 | Sep 30, 2015 | $71.00M | +2.2% |
| FY2014 | Sep 30, 2014 | $69.50M | +0.3% |
| FY2013 | Sep 30, 2013 | $69.30M | -38.4% |
| FY2012 | Sep 30, 2012 | $112.50M | +3.9% |
| FY2011 | Sep 30, 2011 | $108.30M | +11.5% |
| FY2010 | Sep 30, 2010 | $97.10M | +7.3% |
| FY2009 | Sep 30, 2009 | $90.50M | -1.3% |
| FY2008 | Sep 30, 2008 | $91.70M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ3 2026 | Sep 30, 2026 | $15.50M | +0.6% |
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $13.30M | -1.5% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $14.90M | +11.2% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $13.80M | +3.0% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $15.40M | +7.7% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $13.50M | -7.5% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $13.40M | -5.6% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $13.40M | +0.8% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $14.30M | -10.1% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $14.60M | -1.4% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $14.20M | -1.4% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $13.30M | -0.7% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $15.90M | +3.2% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $14.80M | +8.8% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $14.40M | +5.1% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $13.40M | +4.7% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $15.40M | +1.3% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $13.60M | -6.8% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $13.70M | -4.2% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $12.80M | -6.6% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $15.20M | 0.0% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $14.60M | +17.7% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $14.30M | +2.9% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $13.70M | -0.7% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $15.20M | +8.6% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $12.40M | -3.9% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $13.90M | -0.7% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $13.80M | +9.5% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $14.00M | -4.1% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $12.90M | -13.4% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $14.00M | -9.7% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $12.60M | -21.7% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $14.60M | -16.1% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $14.90M | -9.1% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $15.50M | -11.4% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $16.10M | -1.2% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $17.40M | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $16.40M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $17.50M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $16.30M | – |
See a number that looks wrong?